New chairman for Array BioPharma

BOULDER — Array BioPharma Inc. (Nasdaq: ARRY) has a new chairman of its board of directors.

Carrie S. Cox has been named chairman. Kyle Lefkoff, general partner of Boulder Ventures Ltd., has stepped down as chairman and will continue to serve as a director.

Cox has a long history in the biopharmaceutical industry, serving as executive vice president and president of Schering-Plough’s Global Pharmaceutical Business. Prior to that, she was executive vice president and president of Pharmacia’s Global Prescription Business, senior vice president of Pharmacia & Upjohn’s Global Prescription Business, and as vice president of Women’s Healthcare at Wyeth-Ayerst.

SPONSORED CONTENT

How dispatchable resources enable the clean energy transition

Platte River must prepare for the retirement of 431 megawatts (MW) of dispatchable, coal-fired generation by the end of the decade and address more frequent extreme weather events that can bring dark calms (periods when there is no sun or wind).